Report And Consolidated Financial Statements

Overview

The report describes the successful completion of analysis from Lupuzor's six-month open-label extension study and its confirmed safety profile. It also highlights the November 2019 Avion agreement for exclusive North American rights and funding of a new international Phase III trial. The company raised approximately £2.66 million through a subscription and completed its dual listing on Euronext Growth Brussels in December 2019.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2019
Period: Ends 31 December 2019
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services